Literature DB >> 30932083

Pediatric precordial pain, Hospital Español de México's experience.

Celia M Ocampo-Vázquez1, Rodrigo Hernández-Benítez2, Jose Iglesias-Leboreiro3, Isabel Bernardez-Zapata3, Mónica M Luna1, Ana P Cervantes-Izaguirre1.   

Abstract

Introduction: Pediatric precordial pain is a frequent cause for pediatric consultation in the emergency room (ER) services - about 0.3-0.6% of all consultations - and it can cause a lot of stress to families who tend to associate it with a more severe pathology, this pathology mostly presents itself between the ages of 11 and 14 years. Objective: The objective of this study was to determine the precordial pain's etiology and to analyze the semiology and approach toward the ailment by ER service in a private hospital.
Methods: A retrospective, observational, descriptive, transversal study that took place from January 2014 to May 2017.
Results: A total of 48 precordial pain patients were identified, four of them had a positive family background. Most of the pain was not referred as associated to symptoms, and the type of pain was non-specific in 62% of the cases. The most frequent duration of the pain was < 8 h in 54.1% and without any irradiation. There was only one case associated with the presence of cardiac precordial pain pathology regarding pulmonary hypertension; this signified an incidence of 2%, similar to what has been previously published in other articles. Copyright:
© 2019 Permanyer.

Entities:  

Keywords:  Dolor precordial; Emergency room; Mexico; México; Pain; Pediatria; Pediatrics; Precordial; Urgencias

Year:  2019        PMID: 30932083     DOI: 10.24875/ACM.M19000004

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  1 in total

1.  A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China.

Authors:  Mingyue Xue; Xiaoping Yang; Yuan Zou; Tao Liu; Yinxia Su; Cheng Li; Hua Yao; Shuxia Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-02       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.